Clinical Features, Differential Diagnosis and Intestinal Mucosal TB-PCR for Intestinal Tuberculosis and Crohn's Disease
HAN Mai,LV Yumin,PEI Fei,YANG Xuesong
DOI: https://doi.org/10.3969/j.issn.1006-5709.2009.09.013
2009-01-01
Abstract:Objective To analyze the difference of clinical,endoscopic and pathological features between intestinal tuberculosis(ITB) and Crohn's disease (CD),and to evaluate the significance of tissue polymerase chain reaction for Mycobacterium tuberculosis(TB-PCR) assay for the differential diagnosis.Methods One hundred and two cases diagnosed as intestinal tuberculosis(42) and CD(60) from Jan.1994 to Dec.2006 were reviewed.The clinical manifestation,endoscopic,histopathological findings,and the result of intestinal mucosal TB-PCR were analyzed.Results Hematochezia was more frequently seen in CD patients(56.9%,33/58) than that in ITB(16.1%,5/31,P0.001).Extraintestinal manifestations such as oral ulcer,skin rash,arthralgia and peri-anal diseases,were seen in 29.3% CD patients compared with none in ITB.Under the endoscope,CD appeared as longitudinal/fissure-like ulcers for 44.9%(22/49),cobblestone mucosa 28.6%(14/49),and segmental lesion 51.0%(25/49),significantly higher than those in ITB(7.7%,3.9%,0,P=0.001,0.011,0.000 respectively).As for histopathological findings,lymphoid aggregation(34%,18/53) and microvasculitis(26.4%,14/53) were more common in CD compared with ITB(0,3.8%,P=0.001,0.016 respectively).82.4%(14/17)ITB patients got symptom improved after 1～2 weeks empirical antituberculous therapy compared with no effect in 5 CD patients after 4～8 weeks antituberculous therapy.There was no significant difference in the assay of intestinal mucosal TB-PCR between ITB group(11.5%,3/26) and CD group(14.3%,3/21) (P0.5).Conclusion We need to take account the clinical features,endoscope,radiological and histological findings to diagnose ITB or CD,and the significance of intestinal mucosal TB-PCR assay is limited for diffeventially diagnosing ITB and CD.For those cases difficult to differentiation,empirical antituberculous therapy and follow-up colonoscopy are necessary.